U.S. Healthtech Stock News

Rocket Lab (RKLB) just followed up a record Q3 with fresh momentum, stacking new government missions, including its upcoming JAXA Raise and Shine launch, on top of a swelling billion dollar plus backlog. See our latest analysis for Rocket Lab. Those contract wins and record results are feeding straight into sentiment, with a 7 day share price return of 27.7 percent and a year to date share price return above 100 percent, signalling powerful, still building momentum despite recent volatility...

In recent days, Collegium Pharmaceutical has been highlighted by Zacks as a top value stock, with consistently positive earnings surprises and strong cash flow metrics that compare favorably with its industry peers. This fresh focus on its valuation and earnings track record underscores how investor attention is increasingly centered on Collegium’s cash-generating pain and ADHD portfolio. We'll now examine how this recognition of Collegium as an undervalued, earnings-consistent value name...

Recent analysis using a two-stage discounted cash flow model estimated Coca-Cola FEMSA’s fair value at about US$163 per share, compared with a current market price of around US$90.50, highlighting a wide gap between modeled intrinsic value and trading levels observed in recent days. This valuation work draws attention to how sensitive Coca-Cola FEMSA’s perceived worth can be to assumptions about discount rates and long-term cash flow growth, potentially encouraging investors to re-examine...

Brinker International recently reported a strong quarter, with revenue rising 18.5% year on year and Chili’s same-store sales beating analyst expectations, even as full-year revenue guidance came in slightly below forecasts. The combination of robust near-term performance and more cautious outlook highlights Brinker's challenge of boosting traffic and margins without relying on significant pricing power amid moderating demand. Now we’ll examine how this strong but cautiously framed quarter,...

H2O America (HTO) just landed on Newsweek’s America’s Most Responsible Companies 2026 list for the second year running, spotlighting its ESG track record and raising fresh questions about how that responsibility translates into valuation. See our latest analysis for H2O America. Even with the fresh Newsweek recognition and recent investments in resilient infrastructure and smart meters, H2O America’s 1 year total shareholder return of negative 9.34 percent and 3 year total shareholder return...

Mendon Capital Advisors recently disclosed in a November 14, 2025 SEC filing that it had established a new position in Simmons First National Corporation, purchasing 406,570 shares valued at US$7.79 million, representing 2.99% of its reportable U.S. equity assets. Because Mendon specializes in U.S. regional banks, its decision to build a meaningful stake in Simmons First National may signal growing institutional interest in the bank’s regional and digital growth story. Next, we’ll examine...

Alexander’s, Inc. recently completed a US$175 million refinancing of its 615,000-square-foot Rego Park II shopping center in Queens, New York, securing an interest-only loan at SOFR plus 2.00%, currently 5.82%, maturing in December 2030 after paying down US$23.5 million on the prior facility. This refinancing extends the debt maturity profile by about five years for one of Alexander’s five New York City properties, potentially reshaping perceptions of its balance sheet flexibility and...

In recent months, Goodyear Tire & Rubber has moved ahead with its Goodyear Forward program, completing roughly US$2.20 billion of divestitures to cut debt while continuing premium product launches and OEM partnerships. These debt-reduction moves are reshaping Goodyear from a traditionally cyclical tire maker into a more focused, self-help story centered on higher-margin core operations and cost savings. Next, we’ll examine how Goodyear’s asset sales and deleveraging push interact with its...

Wave Life Sciences (WVE) has quietly delivered powerful gains this year, with the stock up roughly 39% year to date and more than tripling over the past 3 years. See our latest analysis for Wave Life Sciences. That surge in 1 week share price return of about 165 percent has turned heads, and with a 3 year total shareholder return nearing 287 percent, momentum now looks firmly in Wave’s favor as investors reassess its growth runway and risk profile. If Wave’s recent jump has you thinking more...

Nu Holdings (NYSE:NU) is back in the spotlight after fresh data highlighted how its tech driven banking model in Latin America is still translating into rising profits and better unit economics, sharpening focus on what the stock is truly worth. See our latest analysis for Nu Holdings. That optimism has not gone unnoticed in the market, with Nu’s share price up a strong year to date on the back of consistent earnings beats and expanding margins. At the same time, recent pullbacks suggest some...

In recent days, Cinemark Holdings reported a weak third quarter, with net income and revenue falling, just as Netflix’s planned acquisition of Warner Bros Discovery raised fresh questions about the future of theatrical release windows for major films. Together, the earnings disappointment and uncertainty around how a combined Netflix–Warner Bros Discovery might prioritize streaming versus theaters are forcing investors to reassess how durable Cinemark’s traditional cinema model may be. Next,...

QCR Holdings (QCRH) just delivered a standout Q3, with revenue and earnings comfortably ahead of Wall Street estimates. The stock has climbed about 20% since, signaling renewed investor conviction in this regional bank. See our latest analysis for QCR Holdings. That upbeat Q3 has capped a strong run, with a 1 month share price return of 13.44% and year to date share price gains contributing to a 3 year total shareholder return of 78.21%, suggesting momentum is building rather than fading. If...

Reinsurance Group of America (RGA) has quietly slipped about 2% over the past week and roughly 11% over the past year, even as its revenue and earnings continue to grow at a solid clip. See our latest analysis for Reinsurance Group of America. At around $188.64, the recent slide in RGA’s share price looks more like a pause than a breakdown. Short term share price pressure contrasts sharply with its robust multi year total shareholder returns, suggesting momentum is cooling but not broken. If...

Molson Coors Beverage recently reported that Madrí Excepcional has surpassed £1.00 billion in annual sales, becoming the UK’s second-largest world lager brand just five years after its launch, while its alcohol-free Madrí Excepcional 0.0% generated more than £1.50 million in revenue in its first six months. This rapid rise of Madrí Excepcional highlights how Molson Coors’ premium and low- or no-alcohol offerings can broaden its portfolio mix and support higher-margin, international...

Stronger earnings, softer reaction IHS Holding (NYSE:IHS) just posted third quarter 2025 earnings that blew past forecasts and raised its full year revenue outlook, yet the stock slipped in pre market trading as investors dug into the details. The company also laid out plans to expand further in Brazil and bring more AI into its operations, while signaling it may consider dividends or buybacks in the future. These moves could reshape how investors think about its growth and capital return...

In its latest update, The Greenbrier Companies reported fiscal Q4 orders for 2,400 railcars worth over US$300 million, delivered 4,900 units, and ended August 2025 with a backlog of 16,600 railcars valued at nearly US$2.20 billion. The company’s lease fleet expanded about 10% in fiscal 2025 with 98% utilization and it paid its 46th consecutive quarterly dividend on December 3, 2025, underscoring sustained demand for its equipment and services. We’ll now examine how this strong railcar...

Corning (GLW) is back on investors radar after its optical communications business again took center stage in the latest earnings update, with AI driven data center demand powering a meaningful jump in sales and profit contribution. See our latest analysis for Corning. That backdrop helps explain why Corning’s share price has climbed to about $88, with a powerful year to date share price return of roughly 89 percent and a three year total shareholder return above 180 percent, signaling...

If we want to find a potential multi-bagger, often there are underlying trends that can provide clues. Typically, we'll...

Barclays has taken a more constructive view on Compass, upgrading the stock after highlighting expected benefits from its HOUS acquisition, an improved pitch to agents, and potential upside as existing home sales gradually recover. See our latest analysis for Compass. That backdrop helps explain why momentum in Compass shares has been building, with a 21.87% 1 month share price return, a 79.66% year to date share price return, and a striking 294.70% 3 year total shareholder return, even...

PPG Industries (PPG) has been drifting lower this year, even as its latest annual results showed steady revenue and earnings growth. That disconnect is what has investors revisiting the coatings giant’s valuation today. See our latest analysis for PPG Industries. Despite a recent 1 month share price return of 4.28 percent, PPG is still down 13.04 percent year to date and its 1 year total shareholder return of negative 18.79 percent underlines that momentum has been fading as investors...

Liberty Energy (LBRT) is back in the spotlight after UBS kicked off coverage with a bullish stance, adding its voice to upbeat views from Citigroup and RBC Capital and sharpening investor focus on the stock. See our latest analysis for Liberty Energy. Those bullish calls land as Liberty Energy trades around $19.40, with a strong 90 day share price return of 93.61 percent contrasting with a softer year to date share price return and a still solid 1 year total shareholder return of 14.10...

Cogent Biosciences (COGT) just cleared an important de risking step by reporting positive APEX Part 2 data for bezuclastinib in advanced systemic mastocytosis, which now underpins its planned FDA filing in 2026. See our latest analysis for Cogent Biosciences. Those APEX and SUMMIT readouts have clearly shifted how investors see Cogent’s risk profile, with a roughly 172 percent 1 month share price return and a 417 percent year to date share price return suggesting momentum is firmly building...

Beacon Pointe Advisors LLC recently disclosed a new position in Dorchester Minerals, L.P. worth about US$1.14 million, coinciding with the partnership’s decision to lift its quarterly distribution to a yield of around 12.0% and fresh insider share purchases by the CEO and a director. This combination of higher income payouts, institutional capital inflows, and insider buying has drawn attention to how Dorchester Minerals’ management and professional investors view the partnership’s prospects...

In early December 2025, SiTime Corporation launched its Endura ENDR-TTT Super-TCXO, an ultra-stable, low-power oscillator engineered to extend GNSS holdover, improve spoofing resistance, and withstand extreme temperatures and shock for aerospace, defense, and industrial timing applications. By offering much longer holdover, far better PNT accuracy, and sharply reduced g-sensitivity versus quartz, the new oscillator aims to address mission-critical timing needs where GNSS signals are...